Vera Therapeutics Inc (VERA)
42.99
-0.45
(-1.04%)
USD |
NASDAQ |
May 06, 11:28
Vera Therapeutics Total Liabilities (Quarterly): 73.86M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 73.86M |
| September 30, 2023 | 51.91M |
| June 30, 2023 | 54.66M |
| March 31, 2023 | 51.90M |
| December 31, 2022 | 54.53M |
| September 30, 2022 | 25.65M |
| June 30, 2022 | 27.28M |
| Date | Value |
|---|---|
| March 31, 2022 | 30.55M |
| December 31, 2021 | 14.16M |
| September 30, 2021 | 5.69M |
| June 30, 2021 | 5.492M |
| March 31, 2021 | 145.14M |
| December 31, 2020 | 143.90M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.492M
Minimum
Jun 2021
145.14M
Maximum
Mar 2021
52.67M
Average
51.90M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 5.150B |
| Alpine Immune Sciences Inc | 51.91M |
| Fate Therapeutics Inc | 137.80M |
| Mersana Therapeutics Inc | 189.16M |
| Equillium Inc | 27.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 175.55M |
| Shareholders Equity (Quarterly) | 101.68M |